Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A randomized control trial of herbal medicine for cancer patients that examined influence of IL-6 and cachexy.

ABSTRACT: Interventions: Hochuekkitou, gosyajinnkigan, keisibukuryogan control Primary outcome(s): MTD, RD,IL-6 Study Design: Parallel Randomized

DISEASE(S): Colorectal Cancer,Pancreatic Cancer

PROVIDER: 2646491 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

herbal medicine

Project description:herbal medicine Raw sequence reads

| PRJNA1371753 | ENA

Effect of herbal medicine (Jodeungsan) on migraine: A double-blind randomized clinical trial.

Project description: Not available

| S-EPMC9440383 | biostudies-literature

The effect of IL-17 signaling inhibition on radiation dermatitis (RD) using a mouse model

Project description:It has been previously shown that there is involvement of IL-17 signaling in the development of severe radiation dermatitis from RNA-sequenicng of human RD skin samples. In this project, we tested the hypothesis using a mouse model of RD previously developed by Liao et al. (PMID: 28406748)

2025-04-01 | GSE262510 | GEO

Dietary supplements and herbal medicine for COVID-19: A systematic review of randomized control trials.

Project description: Not available

| S-EPMC8166807 | biostudies-literature

Acupuncture paired with herbal medicine for prediabetes: study protocol for a randomized controlled trial.

Project description: Not available

| S-EPMC5490211 | biostudies-literature

Traditional Vietnamese herbal medicine TD0015 in Knee Osteoarthritis: A Phase-II randomized controlled trial.

Project description: Not available

| S-EPMC12022478 | biostudies-literature

herbal medicine metagenome

Project description:herbal medicine metagenome Raw sequence reads

| PRJNA1222584 | ENA

Safe and effective immunostimulatory therapy through vector-controlled cytokine delivery

Project description:Systemic administration of interleukin (IL)-12 has been shown to induce potent anti-tumor immune responses in preclinical cancer models. Previous clinical trials using bolus IL-12 injection through maximal tolerable dosing (MTD) strategies indicated limited efficacy alongside unwanted side-effects. Our group developed IL-12-loaded PLGA nanospheres (IL12ns) that release their contents systemically in a slow, controlled manner. An immune diagnostic platform (IDP), capable of monitoring therapeutic response through peripheral blood sampling, was designed alongside this immunostimulatory therapy. The systemic immune responses from MTD and IL12ns dosing strategies were analyzed using this IDP in healthy mice. Importantly, the MTD was associated with aberrant peripheral immune stimulation, evidenced by increased IL-12, interferon gamma (IFNG), and IL-10 signaling. The immune-protective effects of IL12ns were supported by increases in pro-inflammatory plasma cytokines/chemokines without the maladaptive transcriptomic signatures in circulating peripheral immune cells. These data ultimately support the necessity of a vector system for safe immunostimulatory IL-12 therapy.

2024-01-16 | GSE241939 | GEO

Combined Lifestyle and Herbal Medicine in Overweight Women with Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial.

Project description: Not available

| S-EPMC5599989 | biostudies-literature

The effect of Chinese herbal medicine on male factor infertility: study protocol for a randomized controlled trial.

Project description: Not available

| S-EPMC11298452 | biostudies-literature